Quibim
Founded 2015 · 116 employees on LinkedIn · 14 known investors
Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies. The company offers modular products for prostate, brain, liver, and breast MRI analysis, plus a data management platform for clinical research and drug development programs.
Investors · 14
Also in the syndicate · 7
Funding
SEC filings, press & company announcements$50M disclosed across 1 of 2 rounds · 2025
- Undisclosed amountSeries AFeb 2025
Amadeus Capital Partners, Asabys Partners, Buenavista, Build Collective, Columbus
Source ↗ - $50MSeries AJan 2025 · 5 sources
Asabys (lead), Buenavista (lead), Amadeus Capital Partners, Apex Ventures, CDTI Innovación, GoHub Ventures, Partech, UI Investissements
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 1
by search overlapCompanies competing with Quibim for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Quibim do?
- Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies. The company offers modular products for prostate, brain, liver, and breast MRI analysis, plus a data management platform for clinical research and drug development programs.
- Who are Quibim's investors?
- Quibim's investors include Adara Ventures, Amadeus Capital Partners, APEX Ventures, LifeX Ventures, Asabys Partners, Columbus Venture Partners, GoHub Ventures.
- How much funding has Quibim raised?
- Quibim has disclosed $50M raised across 1 of its 2 known rounds.




